Tempus has built the world’s largest library of clinical & molecular data and an operating system to make that data accessible and useful, starting with cancer.

Tempus Unlimited exists to provide a continuum of community based services that support the efforts of children and adults with disabilities to live as independently as possible in the least …

Tempus uses data and artificial intelligence (AI) to create precision medicine services, including diagnostics, [5] for oncology, cardiology, radiology, and depression. The company went public …

Dec 18, 2025 · Tempus AI is rated a strong buy for risk-tolerant investors, leveraging its vast proprietary healthcare data to drive precision medicine via AI and ML. Learn more on TEM …

TEMPUS® is a technology company that has built the world's largest library of clinical and molecular data and an operating system to make that information accessible and useful for …

Aug 19, 2025 · Tempus AI, Inc. TEM is rapidly expanding its partnerships across oncology and neuroscience, leveraging its AI platforms — Lens and Next — to accelerate precision medicine.

Tempus AI, Inc. (NASDAQ: TEM) is a technology company leading the adoption of AI to advance precision medicine. Tempus is making precision medicine a reality by applying AI in healthcare,...

Launched in the United States in 2015, Tempus is now one of the largest sequencers of cancer patients in the world. Having built its platform for oncology, it has expanded to …

Aug 11, 2025 · As the industry pivots toward data-driven solutions to address rising costs and complex patient needs, Tempus emerges as a leader, particularly in oncology, by leveraging …

Tempus prides itself in meeting your business' unique needs. Our custom solutions grow with your business, and US-based support means you'll have help when you need it.